Joel Greenblatt's BRKR Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 258,817 shares of Bruker Corporation (BRKR) worth $8.41 M, representing 0.04% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Joel Greenblatt has maintained a long-term strategic position in BRKR, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2014, adding 803,474 shares. Largest reduction occurred in Q2 2015, reducing 777,706 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Bruker Corporation (BRKR) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bruker Corporation (BRKR) Trades by Joel Greenblatt
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +33,523 | Add 0.00% | 33,522 | $16.14 |
| Q3 2013 | -33,522 | Sold Out | 33,522 | $0.00 |
| Q1 2014 | +94,974 | New Buy | 94,974 | $22.79 |
| Q2 2014 | +803,474 | Add 845.99% | 898,448 | $24.27 |
| Q3 2014 | +542,068 | Add 60.33% | 1.44 M | $18.51 |
| Q4 2014 | +205,879 | Add 14.29% | 1.65 M | $19.62 |
| Q1 2015 | -742,587 | Reduce 45.10% | 903,808 | $18.47 |
| Q2 2015 | -777,706 | Reduce 86.05% | 126,102 | $20.41 |
| Q3 2015 | -126,102 | Sold Out | 126,102 | $0.00 |
| Q1 2016 | +712,459 | New Buy | 712,459 | $28.00 |
| Q2 2016 | -460,859 | Reduce 64.69% | 251,600 | $22.74 |
| Q3 2016 | -251,600 | Sold Out | 251,600 | $0.00 |
| Q4 2016 | +13,320 | New Buy | 13,320 | $21.17 |
| Q1 2017 | +35,401 | Add 265.77% | 48,721 | $23.34 |
| Q2 2017 | +28,931 | Add 59.38% | 77,652 | $28.83 |
| Q3 2017 | -77,652 | Sold Out | 77,652 | $0.00 |
| Q1 2018 | +68,745 | New Buy | 68,745 | $29.92 |
| Q2 2018 | +43,779 | Add 63.68% | 112,524 | $29.04 |
| Q3 2018 | +20,322 | Add 18.06% | 132,846 | $33.45 |
| Q4 2018 | -35,040 | Reduce 26.38% | 97,806 | $29.77 |
| Q1 2019 | +62,375 | Add 63.77% | 160,181 | $38.44 |
| Q2 2019 | -13,325 | Reduce 8.32% | 146,856 | $49.95 |
| Q3 2019 | -128,146 | Reduce 87.26% | 18,710 | $43.93 |
| Q4 2019 | -5,836 | Reduce 31.19% | 12,874 | $50.96 |
| Q1 2020 | -28 | Reduce 0.22% | 12,846 | $35.89 |
| Q2 2020 | +1,754 | Add 13.65% | 14,600 | $40.68 |
| Q3 2020 | -7,771 | Reduce 53.23% | 6,829 | $39.68 |
| Q4 2020 | -6,829 | Sold Out | 6,829 | $0.00 |
| Q2 2021 | +17,426 | New Buy | 17,426 | $75.98 |
| Q3 2021 | -6,665 | Reduce 38.25% | 10,761 | $78.06 |
| Q4 2021 | +116 | Add 1.08% | 10,877 | $83.94 |
| Q1 2022 | -4,189 | Reduce 38.51% | 6,688 | $64.29 |
| Q2 2022 | +5,204 | Add 77.81% | 11,892 | $62.73 |
| Q3 2022 | -8,065 | Reduce 67.82% | 3,827 | $53.04 |
| Q4 2022 | +1,638 | Add 42.80% | 5,465 | $68.35 |
| Q1 2023 | -5,465 | Sold Out | 5,465 | $0.00 |
| Q2 2023 | +18,527 | New Buy | 18,527 | $73.92 |
| Q3 2023 | +23,353 | Add 126.05% | 41,880 | $62.30 |
| Q4 2023 | -23,235 | Reduce 55.48% | 18,645 | $73.48 |
| Q1 2024 | +2,080 | Add 11.16% | 20,725 | $93.94 |
| Q2 2024 | +22,615 | Add 109.12% | 43,340 | $63.81 |
| Q3 2024 | -247 | Reduce 0.57% | 43,093 | $69.06 |
| Q4 2024 | +63,231 | Add 146.73% | 106,324 | $58.62 |
| Q1 2025 | +23,438 | Add 22.04% | 129,762 | $41.74 |
| Q2 2025 | +433,515 | Add 334.08% | 563,277 | $41.20 |
| Q3 2025 | -304,460 | Reduce 54.05% | 258,817 | $32.49 |
Joel Greenblatt's Bruker Corporation Investment FAQs
Joel Greenblatt first purchased Bruker Corporation (BRKR) in Q2 2013, acquiring 33,522 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Bruker Corporation (BRKR) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt's largest addition to Bruker Corporation (BRKR) was in Q2 2014, adding 898,448 shares worth $21.8 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 258,817 shares of Bruker Corporation (BRKR), valued at approximately $8.41 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Bruker Corporation (BRKR) represents approximately 0.04% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt's peak holding in Bruker Corporation (BRKR) was 1,646,395 shares, as reported at the end of Q4 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.